Chemical Structure : CLEC-2 inhibitor MAS9
CAS No.: 514185-12-7
货号: PC-24478Not For Human Use, Lab Use Only.
MAS9 is a specific small molecule inhibitor targeting the C-type lectin-like receptor-2 (CLEC-2)-podoplanin interaction with IC50 of 4.5 uM, inhibits CLEC-2-mediated platelet aggregation.
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 2 mg | ¥1980 | In stock | |
| 5 mg | ¥3280 | In stock | |
| 10 mg | ¥5280 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
MAS9 is a specific small molecule inhibitor targeting the C-type lectin-like receptor-2 (CLEC-2)-podoplanin interaction with IC50 of 4.5 uM, inhibits CLEC-2-mediated platelet aggregation.
MAS9 (20-30 uM) significantly inhibits platelet aggregation to both CLEC-2 agonists rhodocytin and hemin.
MAS9 displaysinhibition for CLEC-2-mediated aggregation over other platelet receptors, GPVI, thromboxane prostanoid (TP) receptor, and proteinase activated receptors (PAR1 and PAR4).
MAS9 also displays selective inhibition of CLEC-2-mediated tyrosine kinase signalling. CLEC-2 and GPVI share similar proximal signalling events, including the phosphorylation and activation of the kinase Syk.
MAS9 has no inhibitory effect either on 0.3 μg·ml−1 CRP-XL or 0.1 U·ml−1 thrombin-mediated platelet aggregation, also shows no inhibitory effect on lower concentrations of thrombin or U46619-mediated aggregation.
MAS9 inhibits CLEC-2-dependent platelet adhesion but inhibits platelet spreading to all substrates.
MAS9 (10-30 uM) inhibits platelet adhesion to human dermal lymphatic endothelial cells.
| 分子量 | 314.39 | |
| 分子式 | C18H22N2O3 | |
| 外观性状 | Solid | |
| 储存条件 |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
ethyl 1-[(8-hydroxy-5-quinolinyl)methyl]-3-piperidinecarboxylate |
|
1. Sowa MA, et al. Br J Pharmacol. 2025 Apr 23. doi: 10.1111/bph.70036.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright